The University of Queensland Diamantina Institute (UQDI) was established in 2007 as the sixth research institute of The University of Queensland. The aim of the Institute is to develop a better understanding of the molecular and cellular basis of disease, and to translate that understanding into practical outcomes for patients. Based at the Translational Research Institute (TRI) at the Princess Alexandra Hospital teaching campus in Brisbane, the Institute has nearly 300 researchers and students who work closely with clinicians in the areas of cancer, immunology and genomic medicine. As the largest partner in TRI, UQDI has built and continues to expand major programs in Cancer, Immunology and Genomic Medicine research, with a particular focus on research aimed at development of new treatments. Details of the research interests of academic staff may be accessed on the Institute's web site at http://www.di.uq.edu.au/research.
The successful Scholar will pursue a PhD degree in cancer research by interrogating cancer genomes using various bioinformatics approaches.